Efficacy of switching to dolutegravir plus rilpivirine, the small-tablet regimen, in patients with dysphagia: two case reports

被引:6
|
作者
Takefumi Suzuki
Nobuko Hara
Morichika Osa
Kazuhisa Misawa
Kazuo Imai
Yuji Fujikura
Takuya Maeda
Wataru Sonehara
Akihiko Kawana
机构
[1] National Defense Medical College Hospital,Department of Pharmacy
[2] National Defense Medical College,Division of Infectious Diseases and Pulmonary Medicine, Department of Internal Medicine
[3] Mishuku Hospital,Department of Pharmacy
[4] Saitama Medical University,Department of Microbiology
[5] Saitama Medical University,Center for Clinical Infectious Diseases and Research
关键词
Dolutegravir; Rilpivirine; Dysphagia; NRTI-sparing;
D O I
10.1186/s40780-017-0093-8
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] The efficacy of scopolamine for patients with Parkinson's disease and depression: Two case reports
    Wang, Shikai
    Guo, Ping
    Feng, Min
    Qian, Mincai
    Shen, Xinhua
    Wang, Gang
    ASIAN JOURNAL OF PSYCHIATRY, 2020, 52
  • [22] Efficacy and safety of switching to abacavir/lamivudine (ABC/3TC) plus rilpivirine (RPV) in virologically suppressed HIV-infected patients on HAART
    R. Palacios
    I. A. Pérez-Hernández
    M. A. Martínez
    M. L. Mayorga
    C. M. González-Domenech
    M. Omar
    J. Olalla
    A. Romero
    J. M. Romero
    I. Pérez-Camacho
    J. Hernández-Quero
    J. Santos
    European Journal of Clinical Microbiology & Infectious Diseases, 2016, 35 : 815 - 819
  • [23] Efficacy and safety of switching to abacavir/lamivudine (ABC/3TC) plus rilpivirine (RPV) in virologically suppressed HIV-infected patients on HAART
    Palacios, R.
    Perez-Hernandez, I. A.
    Martinez, M. A.
    Mayorga, M. L.
    Gonzalez-Domenech, C. M.
    Omar, M.
    Olalla, J.
    Romero, A.
    Romero, J. M.
    Perez-Camacho, I.
    Hernandez-Quero, J.
    Santos, J.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2016, 35 (05) : 815 - 819
  • [24] Reduced soluble CD14 levels after switching from a dual regimen with lamivudine plus boosted protease inhibitors to lamivudine plus dolutegravir in virologically suppressed HIV-infected patients
    Lombardi, Francesca
    Belmonti, Simone
    Borghetti, Alberto
    Ciccullo, Arturo
    Baldin, Gianmaria
    Cauda, Roberto
    Fabbiani, Massimiliano
    Di Giambenedetto, Simona
    HIV RESEARCH & CLINICAL PRACTICE, 2019, 20 (03) : 92 - 98
  • [25] Switching to a single-tablet regimen bictegravir, emtricitabine, and tenofovir alafenamide (B/F/TAF) from dolutegravir (DTG) plus emtricitabine and either tenofovir alafenamide or tenofovir disoproxil fumarate (F/TAF or F/TDF)
    Sax, P. E.
    Rockstroh, J.
    Luetkemeyer, A.
    Yasdanpanah, Y.
    Ward, D.
    Trottier, B.
    Rieger, A.
    Liu, H.
    Acosta, R.
    Collins, S. E.
    Brainard, D.
    Martin, H.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2019, 22 : 3 - 4
  • [26] Effectiveness and tolerability of dolutegravir and abacavir/lamivudine administered as two separate pills compared to their equivalent single-tablet regimen in treatment-naive and treatment-experienced patients
    Suarez-Garcia, I.
    Alejos, B.
    Ruiz-Alguero, M.
    Garcia Yubero, C.
    Moreno, S.
    Martin-Pena, M. L.
    Estrada, V.
    Munoz Sanchez, J.
    Novella Mena, M.
    Montero-Alonso, M.
    del Romero, J.
    Santos, J.
    Poveda, E.
    Jarrin, I.
    HIV MEDICINE, 2021, 22 : 93 - 93
  • [27] High virological failure rate in HIV patients after switching to a regimen with two nucleoside reverse transcriptase inhibitors plus tenofovir
    Pérez-Elías, MJ
    Moreno, S
    Gutiérrez, C
    López, D
    Abraira, V
    Moreno, A
    Dronda, F
    Casado, JL
    Antela, A
    Rodríguez, MA
    AIDS, 2005, 19 (07) : 695 - 698
  • [28] Effectiveness of Combining Behavioral Treatment With Valproic Acid for Dysphagia Caused by Palatal Myoclonus in Patients With Stroke: Two Case Reports
    Kim, Bo-Ram
    Lee, Yejin
    Kim, Soo Jin
    Kim, Hyuntae
    Lee, Jong Won
    Lee, Seunghwan
    Lee, Jongmin
    ANNALS OF REHABILITATION MEDICINE-ARM, 2018, 42 (01): : 180 - 183
  • [29] Durable efficacy of switching from a three-/four-drug tenofovir alafenamide (TAF)-based regimen to the two-drug regimen dolutegravir/lamivudine (DTG/3TC) in the TANGO study through week 196
    De Wit, S.
    Bonnet, F.
    Osiyemi, O.
    Bisshop, F.
    Olalla, J.
    Routy, J.
    Wyen, C.
    Moodley, R.
    Pappa, K.
    Wang, R.
    Oyee, J.
    Saggu, P.
    Letang, E.
    Wynne, B.
    Jones, B.
    Smith, K.
    Ait-Khaled, M.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 12 - 13
  • [30] Assessing the Safety and Efficacy of Electroconvulsive Therapy in Patients with Active Deep Brain Stimulation: Two Case Reports
    Pinard, Krista
    Solomon, Louis
    Ward, Herbert
    JOURNAL OF ECT, 2016, 32 (03) : 214 - 215